GDAR Stock Overview

Golden Age Resources Inc., an acquisition and development company, focus on the development of prescription and over the counter medicines in the United States. More details

GDAR fundamental analysis
Snowflake Score
Valuation	0/6
Future Growth	0/6
Past Performance	0/6
Financial Health	0/6
Dividends	0/6

Risk Analysis

Does not have a meaningful market cap ($3K)

Has not reported any financial data

Shares are highly illiquid

My Notes

Capture your thoughts, links and company narrative

Golden Age Resources, Inc. Competitors

Ampio Pharmaceuticals

OTCPK:AMPE

US$11.4k

Lucy Scientific Discovery

OTCPK:LSDI.F

US$176.0

Hero Technologies

OTCPK:HENC

US$563.0

BZAM

OTCPK:BZAM.F

US$2.7k

Price History & Performance

Summary of share price highs, lows and changes for Golden Age Resources
Historical stock prices
Current Share Price	US$0.000001
52 Week High	US$0.000001
52 Week Low	US$0.000001
Beta	0
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	-99.00%
Change since IPO	-100.00%

Recent News & Updates

No updates

Recent updates

No updates

Shareholder Returns

	GDAR	US Pharmaceuticals	US Market
7D	0%	1.2%	-0.3%
1Y	n/a	1.1%	20.4%

Return vs Industry: Insufficient data to determine how GDAR performed against the US Pharmaceuticals industry.

Return vs Market: Insufficient data to determine how GDAR performed against the US Market.

Price Volatility

Is GDAR's price volatile compared to industry and market?
GDAR volatility
GDAR Average Weekly Movement	n/a
Pharmaceuticals Industry Average Movement	10.4%
Market Average Movement	6.0%
10% most volatile stocks in US Market	18.5%
10% least volatile stocks in US Market	3.0%

Stable Share Price: GDAR's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine GDAR's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2008	n/a	Daniel Kogan	www.gdarinc.com

Golden Age Resources Inc., an acquisition and development company, focus on the development of prescription and over the counter medicines in the United States. The company offers its products in the areas of cardiovascular, anti-microbial, immunity, arthritis, pain relief, and other therapeutic areas. Its product portfolio include Nitrosorbid, a vasodilator for the treatment of angina pectoris; Ampicillin Trihydrate, an antibiotic-penicillin; Analgin, a pain relief; Corvalol to treat neuroses with heightened irritability/insomnia/hypertension/non-acute spasm of coronary vessels/tachycardia/gastrointestinal cramping; Tubosan, an immune stimulator; and Lovastatin for the treatment of dyslipidemia, as well as for the prevention of cardiovascular diseases.

Golden Age Resources, Inc. Fundamentals Summary

How do Golden Age Resources's earnings and revenue compare to its market cap?
GDAR fundamental statistics
Market cap	US$3.38k
Earnings (TTM)	US$0
Revenue (TTM)	n/a

n/a

P/E Ratio

n/a

P/S Ratio

Is GDAR overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
GDAR income statement (TTM)
Revenue	US$0
Cost of Revenue	US$0
Gross Profit	US$0
Other Expenses	US$0
Earnings	US$0

Last Reported Earnings

n/a

Next Earnings Date

n/a

Earnings per share (EPS)	0
Gross Margin	0.00%
Net Profit Margin	0.00%
Debt/Equity Ratio	0.0%

How did GDAR perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2025/02/07 19:51
End of Day Share Price	2025/01/03 00:00
Earnings	N/A
Annual Earnings	N/A

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Golden Age Resources, Inc. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.